Still, since 2018, fewer than 12,000 people have been treated with a regimen including bedaquiline, according to MSF's survey of national TB programs. Medecins Sans Frontieres ( MSF ) has called on Johnson & Johnson to cut the price of "gamechanging" tuberculosis ( MSF ) drug bedaquline by half , so that a 20-month supply would cost $ 900 . Sharonann Lynch , a policy adviser at Sharonann Lynch , criticised the U.S. system in which non-profit and philanthropic contributors to a drug's development had no say in its final price. In 2014 , when Kumar was commercially launched, a six-month supply cost $ 900 . The treatment offers an alternative to injections, which have toxic side effects, for people with drug-resistant tuberculosis.
Medecins Sans Frontieres ( MSF ) has called on Johnson & Johnson to cut the price of "gamechanging" tuberculosis ( MSF ) drug bedaquline by half , so that a 20-month supply would cost $ 900 . Sharonann Lynch , a policy adviser at Sharonann Lynch , criticised the U.S. system in which non-profit and philanthropic contributors to a drug's development had no say in its final price. In 2014 , when Kumar was commercially launched, a six-month supply cost $ 900 . The treatment offers an alternative to injections, which have toxic side effects, for people with drug-resistant tuberculosis.